Clinical Brain Tumor Development of a Cytomegalovirus-targeted Therapeutic with Vaccine pre-conditioning to Validate Novel Predictors of Vaccine Efficacy

Administered By

Awarded By

Contributors

Start/End

  • December 1, 2018 - November 30, 2023